<DOC>
	<DOCNO>NCT02622776</DOCNO>
	<brief_summary>This pilot study first step development new assay may test screen method ovarian endometrial cancer .</brief_summary>
	<brief_title>Advanced Methods Cancer Detection Vaginal Screening</brief_title>
	<detailed_description>Most high grade ovarian cancer originate fallopian tube . Since line fallopian tube open uterine cavity cancer cell ovarian/fallopian tube cancer travel uterus cervix vagina . Likewise , endometrial cancer cell shed cervix vagina . It may possible develop screen test ovarian endometrial cancer collect vaginal cell .</detailed_description>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<criteria>Ovarian Cancer Endometrial Cancer case : 1 . Women age 19 old . 2 . Histologically confirm high grade serous cancer ( preoperative core biopsy ) ovarian/fallopian tube/peritoneal origin histocytologically confirm endometrial cancer , yet treat surgery chemotherapy . 3 . Give consent access primary tumour tissue follow surgery biopsy . Healthy participant : 1 ) Healthy woman age 19 60 . Ovarian Cancer Endometrial Cancer case : 1 . Women selfreported , know pregnancy . Healthy participant : 2 . Women prior diagnosis gynecologic malignancy ( ovarian , endometrial , cervical , vulvar cancer ) exclude . 3 . Women report irregular bleeding ( spot menstrual cycle , postmenopausal bleeding ) , selfreported gynecologic concern ( e.g . pelvic pain , pelvic mass , dyspareunia ) recent evaluation gynecologic concern ( consultation gynecologist , pelvic ultrasound , endometrial biopsy ) ineligible . 4 . Women know Lynch Syndrome and/or BRCA1 BRCA2 germline mutation eligible participate healthy volunteer study . 5 . Women selfreported , know pregnancy .</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>